Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically...

Area of Science:

• Cardiology
• Pharmacology
• Critical Care Medicine

Background:

• Excessive bleeding is a significant complication in cardiac surgery, increasing morbidity and mortality.
• Previous trials showed pharmacological agents reduce blood loss but often lacked power for clinical outcomes.
• A meta-analysis was conducted on aprotinin, lysine analogues, and desmopressin for perioperative bleeding reduction.

Purpose of the Study:

• To evaluate the efficacy of three pharmacological strategies in reducing perioperative bleeding in cardiac surgery.
• To assess the impact of these strategies on clinically relevant outcomes, including mortality and transfusion rates.

Main Methods:

• Meta-analysis of 72 randomized controlled trials involving 8409 patients.
• Inclusion criteria required reporting of clinical outcomes (mortality, rethoracotomy, transfusion, myocardial infarction) alongside blood loss.
• Separate analysis for studies on complicated cardiac surgery.

Main Results:

• Aprotinin nearly halved mortality (OR 0.55) and, with lysine analogues, reduced rethoracotomy rates (OR 0.37-0.44).
• Both aprotinin and lysine analogues significantly decreased allogeneic blood transfusion requirements.
• Desmopressin showed minimal blood loss reduction without clinical benefit and increased myocardial infarction risk (OR 2.4).

Conclusions:

• Pharmacological agents, particularly aprotinin and lysine analogues, effectively reduce perioperative blood loss in cardiac surgery.
• These agents are associated with decreased mortality, rethoracotomy, and transfusion rates.
• Desmopressin is not recommended due to lack of clinical benefit and increased risk of myocardial infarction.